Ma'an Nasir

Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration

Robert L. Avery, Dante J. Pieramici, Melvin Rabena et al. · Ophthalmology · 2006 · 1.1K citations

Medicine, Ophthalmology, Pharmacotherapy +14

Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy

Robert L. Avery, Joel Pearlman, Dante J. Pieramici et al. · Ophthalmology · 2006 · 802 citations

Medicine, Ophthalmology, Pharmacotherapy +13

Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD

Robert L. Avery, Alessandro Castellarin, Nathan Steinle et al. · British Journal of Ophthalmology · 2014 · 374 citations · Full text

Medicine, Ophthalmology, Pharmacokinetics +16

SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB

Robert L. Avery, Alessandro Castellarin, Nathan Steinle et al. · Retina · 2017 · 341 citations · Full text

Medicine, Clinical Pharmacokinetics, Pharmacology +17

INTRAVITREAL BEVACIZUMAB (AVASTIN) IN THE TREATMENT OF MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION

Melvin Rabena, Dante J. Pieramici, Alessandro Castellarin et al. · Retina · 2007 · 244 citations

Medicine, Ophthalmology, Pharmacotherapy +17